Market Place
Sourcing Support
Black Diamond Reports Q3 2024 Financial Results & Corporate Update
05 Nov 2024 //
GLOBENEWSWIRE
Black Diamond Therapeutics to Participate in Investor Conferences
01 Nov 2024 //
GLOBENEWSWIRE
Black Diamond reshuffles execs, drops phase 1 lung cancer drug
08 Oct 2024 //
FIERCE BIOTECH
Black Diamond Announces Restructuring To Focus On BDTX-1535
07 Oct 2024 //
GLOBENEWSWIRE
Black Diamond Announce BDTX-1535 Phase 2 Data In EGFRm NSCLC
23 Sep 2024 //
GLOBENEWSWIRE
Black Diamond Therapeutics Presents NSCLC Real-World Data At ESMO 2024
14 Sep 2024 //
GLOBENEWSWIRE
Black Diamond Therapeutics Reports Q2 2024 Results And Corporate Update
06 Aug 2024 //
GLOBENEWSWIRE
BDTX-1535 Promising In Recurrent Glioblastoma At ASCO 2024
01 Jun 2024 //
GLOBENEWSWIRE
Black Diamond At Jefferies Healthcare Conference
29 May 2024 //
GLOBENEWSWIRE
Black Diamond Therapeutics Q1 2024 Financials And Update
09 May 2024 //
GLOBENEWSWIRE
Black Diamond to Present at ASCO 2024 Annual Meeting
24 Apr 2024 //
GLOBENEWSWIRE
Black Diamond Therapeutics Presents Data of BDTX-1535 at the 2024 AACR
07 Apr 2024 //
GLOBENEWSWIRE
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
03 Apr 2024 //
GLOBENEWSWIRE
Black Diamond Reports Fourth Quarter and Full Year 2023 Financial Results
12 Mar 2024 //
GLOBENEWSWIRE
Black Diamond Announces Upcoming Presentation at AACR Annual Meeting 2024
05 Mar 2024 //
GLOBENEWSWIRE
Black Diamond to Participate in the TD Cowen 44th Annual Health Care Conference
28 Feb 2024 //
GLOBENEWSWIRE
Black Diamond Therapeutics Announces Corporate Update & Expected 2024 Milestones
04 Jan 2024 //
GLOBENEWSWIRE
Black Diamond Announces Topline Results from Phase 1 Trial of BDTX-1535
13 Dec 2023 //
GLOBENEWSWIRE
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
07 Nov 2023 //
GLOBENEWSWIRE
Black Diamond Therapeutics Reports Third Quarter 2023 Financial Results
06 Nov 2023 //
GLOBENEWSWIRE
Black Diamond Presents Data Demonstrating Responses in Patients with NSCLC
14 Oct 2023 //
GLOBENEWSWIRE
Black Diamond to Present Preclinical and Clinical Data at the AACR-NCI-EORTC
04 Oct 2023 //
GLOBENEWSWIRE
Black Diamond Therapeutics Announces CEO Transition
18 Sep 2023 //
GLOBENEWSWIRE
Black Diamond Announces First Patients Dosed in Ph 1 Trial Evaluating BDTX-1535
11 Sep 2023 //
GLOBENEWSWIRE
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
05 Sep 2023 //
GLOBENEWSWIRE
Black Diamond Therapeutics Reports Second Quarter 2023 Financial Results
11 Aug 2023 //
GLOBENEWSWIRE
Black Diamond Therapeutics Announces Pricing of Public Offering of Common Stock
29 Jun 2023 //
GLOBENEWSWIRE
Black Diamond Therapeutics Announces Proposed Public Offering of Common Stock
28 Jun 2023 //
GLOBENEWSWIRE
Black Diamond Announces Initial Dose Escalation Data Anti-Tumor of BDTX-1535
27 Jun 2023 //
GLOBENEWSWIRE
Black Diamond Therapeutics Announces Promotion of Melanie Morrison to CDO
13 Jun 2023 //
GLOBENEWSWIRE
Black Diamond Therapeutics to Present at the Jefferies Healthcare Conference
02 Jun 2023 //
GLOBENEWSWIRE
Black Diamond Therapeutics Reports1Q 2023 FYR and Provides Corporate Update
09 May 2023 //
GLOBENEWSWIRE
Black Diamond Therapeutics Presents Trial in Progress Poster for BDTX-1535
17 Apr 2023 //
GLOBENEWSWIRE
Black Diamond Reports Fourth Quarter and Full Year 2022 Financial Results
09 Mar 2023 //
GLOBENEWSWIRE
Black Diamond to Present at the Cowen 43rd Annual Health Care Conference
27 Feb 2023 //
GLOBENEWSWIRE
Black Diamond Therapeutics to Present at the 41st J.P. Morgan Conference
05 Jan 2023 //
GLOBENEWSWIRE
Black Diamond Therapeutics Announces Changes to Board of Directors
19 Dec 2022 //
GLOBENEWSWIRE
Black Diamond spins out antibody work into biotech with $30M from Versant, NEA
12 Dec 2022 //
ENDPTS
Black Diamond Therapeutics Announces Spinout of Launchpad Therapeutics
12 Dec 2022 //
GLOBENEWSWIRE
Black Diamond Therapeutics Presents Preclinical Data on BDTX-1535 and BDTX-4933
26 Oct 2022 //
GLOBENEWSWIRE
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
06 Sep 2022 //
GLOBENEWSWIRE
Black Diamond Therapeutics Reports Second Quarter 2022 Financial Results
09 Aug 2022 //
GLOBENEWSWIRE
Black Diamond Therapeutics to Present at the 2022 Wedbush Virtual Conference
03 Aug 2022 //
GLOBENEWSWIRE
Black Diamond Therapeutics to Present at Jefferies Global Healthcare Conference
06 Jun 2022 //
GLOBENEWSWIRE
Black Diamond Therapeutics Appoints Sergey Yurasov, M.D., Ph.D., as CMO
01 Jun 2022 //
GLOBENEWSWIRE
Black Diamond Therapeutics Announces Publication on HER2 Mutations
12 May 2022 //
GLOBENEWSWIRE
Black Diamond runs into rocky terrain, trims 30% of workforce
25 Apr 2022 //
FIERCEBIOTECH
Black Diamond Therapeutics Announces Pipeline Prioritization and Workforce
25 Apr 2022 //
GLOBENEWSWIRE
Black Diamond Begins Dosing in Phase 1 Study of BDTX-1535
18 Apr 2022 //
GLOBENEWSWIRE
Black Diamond Therapeutics Appoints Wendy L. Dixon to its Board of Directors
07 Apr 2022 //
GLOBENEWSWIRE
Black Diamond to Present at Canaccord Genuity Horizons in Oncology Conference
07 Apr 2022 //
GLOBENEWSWIRE
Black Diamond Tx Reports Q4 and FY 2021 Financial Results
17 Mar 2022 //
GLOBENEWSWIRE
Black Diamond Tx to Participate at Cowen 42nd Annual Health Care Conference
02 Mar 2022 //
GLOBENEWSWIRE
FDA Clears Black Diamond`s IND Application for BDTX-1535 in Gliobastoma & NSCLC
11 Jan 2022 //
GLOBENEWSWIRE
Black Diamond Announces Strategic Priorities and Expected Milestones for 2022
10 Jan 2022 //
GLOBENEWSWIRE
Black Diamond Therapeutics Presents Preclinical Data on BDTX-1535, BRAF
08 Oct 2021 //
GLOBENEWSWIRE
Black Diamond to Host Webcast Presentation of Data From Phase 1 Dose
17 May 2021 //
GLOBENEWSWIRE
Black Diamond Therapeutics to Present Phase 1 BDTX-189 Data
28 Apr 2021 //
GLOBENEWSWIRE
Black Diamond Therapeutics to Present Pre-Clinical Data on BDTX-189
10 Mar 2021 //
GLOBENEWSWIRE
Black Diamond`s EFGR-targeted glioblastoma drug candidate slows tumor
23 Nov 2020 //
FIERCEBIOTECH
